FDA Approved: CYSVIEW — Original Application (Photocure Inc.)

View source ↗

Summary

CYSVIEW (hexaminolevulinate hydrochloride) was approved by the FDA as an imaging agent to be used with blue-light cystoscopy to help detect bladder cancer durin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma of the Bladder

Drugs mentioned

• Cysview (hexaminolevulinate hydrochloride)

Snippet

ORIG AP for CYSVIEW (HEXAMINOLEVULINATE HYDROCHLORIDE)